Tirzepatide

In the last 2 hours
New weight loss pharmacy opens in Marquette Township Upper Michigan Source21:50
New study finds obesity costs US industry $347bn a year Pharmaceutical Technology21:42
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with… GlobeNewswire (Press Release)21:39
In the last 6 hours
Nature study finds obesity costs US industry $347bn a year Pharmaceutical Technology18:39
Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to Consumers? Medpage Today17:37
In the last 8 hours
The Lymphoma Research Foundation's CEO Previews Hot Topics at ASH 2024 American Journal of Managed Care15:45
AJMC® in the Press, December 6, 2024 American Journal of Managed Care15:04
Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks15:03
Earlier today
Lilly invests another $3bn in its manufacturing network pharmaphorum14:37
How the weight loss drug tirzepatide is also helping heart failure patients Science News Online14:15
Weight loss drug Mounjaro will be available via the NHS for some people living with obesity Women's Health UK14:12
Can You Go On Ozempic If You Want To Get Pregnant? Women's Health13:23
How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study Zacks12:30
NICE accepts slower rollout of tirzepatide Nursing in Practice11:36
This Week in Health News: 13 Stories You Need to See PR Newswire (Press Release)11:15
Elsa Hosk turns heads in a strapless satin minidress as she joins a glamorous Brooks Nader at… MailOnline11:04
Atlas closes $450m biotech fund, and other financing news pharmaphorum09:42
Eli Lilly $3 billion expansion in Kenosha County is company's largest outside Indiana Kenosha News00:29
Yesterday
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial Investopedia23:41 5-Dec-24
COVID-19 Infection Increases Risk of Severe Outcomes in Patients With Certain Cardiomyopathies American Journal of Managed Care21:05 5-Dec-24
Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars Yahoo! UK & Ireland20:46 5-Dec-24
How Tirzepatide Benefits Patients With Obesity-Related HFpEF American Journal of Managed Care17:52 5-Dec-24
What is new weight loss jab Mounjaro and is it available on the NHS? Manchester Evening News16:53 5-Dec-24
Tirzepatide: Obesity injection will get phased rollout to avoid overwhelming GPs British Medical Journal16:07 5-Dec-24
Tirzepatide Outperforms Semaglutide in Weight Loss Trial American Journal of Managed Care15:49 5-Dec-24
Proposal for Medicaid, Medicare Coverage of Obesity Drugs Could Prove Difficult American Journal of Managed Care14:38 5-Dec-24
Who is eligible for the NHS' weight loss jab Mounjaro? Yahoo! UK & Ireland14:03 5-Dec-24
Watchdog clamps down on illegal ‘skinny jab’ ads targeting ‘vulnerable people’ ITV13:59 5-Dec-24
NICE recommends Lilly’s tirzepatide for managing overweight and obesity Pharmaceutical Field12:50 5-Dec-24
NHS Mounjaro warning as most will not be able to access new weightloss drug Daily Record12:43 5-Dec-24
Mounjaro: What you need to know about ‘King Kong of weight-loss drugs’ The Independent12:06 5-Dec-24
Tirzepatide approved by NICE The Diabetes Times11:51 5-Dec-24
What is Mounjaro and how does it work? Evening Standard11:46 5-Dec-24
How new NHS weight loss jab Mounjaro works and eligibility amid 12-year waiting list The Mirror11:27 5-Dec-24
What is Mounjaro – the new NHS weight loss jab? Metro.co.uk11:26 5-Dec-24
LLY's Zepbound Outshines NVO's Wegovy in Head-to-Head Obesity Study Zacks11:03 5-Dec-24
Warning over impact on GPs as NICE announces three-year tirzepatide rollout GPonline.com10:56 5-Dec-24
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy? The Motley Fool10:32 5-Dec-24
Mounjaro cleared for NHS use, but patients may have to wait pharmaphorum10:16 5-Dec-24
Doctor warns of deadly unforeseen side effects of Mounjaro as NHS is given 12 years to roll out … MailOnline10:11 5-Dec-24
Patients face 12-year wait for 'King Kong of weight loss drugs' on NHS i News06:37 5-Dec-24
NHS will deny weight loss jab to 90pc of obese patients Yahoo! UK & Ireland06:25 5-Dec-24
Millions of obese people to be refused 'King Kong of weight loss drugs' on NHS as they face 12-year wait for rollout LBC News06:22 5-Dec-24
Brooks Nader admits she used Ozempic before Dancing With The Stars but quit over common… MailOnline04:31 5-Dec-24
NHS gets 12 years to roll out new weight-loss drug BBC01:18 5-Dec-24
expert reaction to NICE final draft guidance on tirzepatide for obesity Science Media Centre00:28 5-Dec-24
Millions to be denied NHS fat jabs as treatment is limited to just 220,000 - fewer than one in… MailOnline00:11 5-Dec-24
NHS Mounjaro warning as 90 per cent of people will be disappointed Plymouth Live00:10 5-Dec-24
Obese people ‘will have to wait’ for Mounjaro amid carefully managed NHS rollout Belfast Telegraph00:08 5-Dec-24
NHS to prescribe ‘King Kong' weight loss jab Mounjaro to the most dangerously obese The Mirror00:03 5-Dec-24
In the last 7 days
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds Fortune23:07 4-Dec-24
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says Medpage Today21:41 4-Dec-24
Tirzepatide Bests Semaglutide in Relative, Average Weight Loss in Obesity, Overweight Drug Topics20:57 4-Dec-24
In new trial, Zepbound bests Wegovy for weight loss UPI19:56 4-Dec-24
GLP-1s: The Medications Redefining Diabetes and Obesity Treatment Medpage Today19:38 4-Dec-24
Can’t Afford Ozempic, Other GLP-1 Drugs? Here’s What to Do, According to Experts Health Magazine19:06 4-Dec-24
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy Clinical Trials Arena17:41 4-Dec-24
Which Weight-Loss Drug Is Better? TIME16:42 4-Dec-24
Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Topline Results TCTMD16:33 4-Dec-24
Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss? Benzinga15:11 4-Dec-24
Zepbound Bests Wegovy for Weight Loss in New Trial HealthDay13:52 4-Dec-24
Eli Lilly weight-loss drug Zepbound beats Wegovy in trial ShareCast13:45 4-Dec-24
Zepbound tops Wegovy in first head-to-head weight-loss trial pharmaphorum13:35 4-Dec-24
Eli Lilly Just Got a Bundle of Good News: Time to Buy? The Motley Fool12:17 4-Dec-24
Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment Clinical Trials Arena11:56 4-Dec-24
Lilly's Zepbound® (tirzepatide) superior to Wegovy® (semaglutide) in head-to-head trial showing … PR Newswire (Press Release)11:46 4-Dec-24
TCTMD’s Top 10 Most Popular Stories for November 2024 TCTMD19:54 3-Dec-24
GLP-1 Drugs: Brand Companies Push FDA to Limit Compounding JD Supra15:35 3-Dec-24
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of… Business Wire (Press Release)12:32 3-Dec-24
The weight is over: How GLP-1 treatments are reshaping pharma and beyond Allianz Trade09:05 3-Dec-24
Hanmi showcases efosipegtrutide's potential for liver fibrosis at AASLD conference Korea Biomedical Review06:33 3-Dec-24
About One-Third Eligible for Weight Loss Drugs Meet Trial Exclusion Criteria HealthDay23:26 2-Dec-24
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study Benzinga16:26 2-Dec-24
Tirzepatide shows strong diabetes-prevention effect in trial Cornell Chronicle14:33 2-Dec-24
This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip? The Motley Fool13:06 2-Dec-24
Benefits of HPV Vaccination; Contraindications to Newer Obesity Drugs Medpage Today19:02 30-Nov-24
Ultimate guide to weight-loss jabs: Top experts answer every question, from what really happens … MailOnline05:12 30-Nov-24
EMA launches ESMP for better management of drug shortages in EU Pharmaceutical Technology17:56 29-Nov-24
Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication News-Medical.Net14:33 29-Nov-24
Type 2 diabetes risk among obese people reduced by tirzepatide, research demonstrates The Diabetes Times11:36 29-Nov-24
In the last month
I don't want my 12-year-old daughter to get obese like me so I've put her on Ozempic… MailOnline21:44 28-Nov-24
Jelly Roll's wife Bunnie XO reveals slimmed-down frame after admitting to 'microdosing' weight… MailOnline17:43 28-Nov-24
Infographic: R&D Spending Growth of Top Pharma Companies Visual Capitalist15:51 28-Nov-24
Expert explores the expanding applications of GLP1 therapies News-Medical.Net15:10 28-Nov-24
Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock? The Motley Fool12:39 28-Nov-24
Denosumab and risk of hypocalcaemia … and other research British Medical Journal11:49 28-Nov-24
The winners and losers of Biden’s plans to expand coverage of weight-loss drugs ING Think07:32 28-Nov-24
American Heart Association, Nov. 16-18 HealthDay21:30 27-Nov-24
Thanksgiving sides you can still enjoy even on weight loss meds Queerty19:09 27-Nov-24
UK medicines watchdog alerted to 18 suspected weight-loss jab deaths ITV18:23 27-Nov-24
CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs TCTMD18:00 27-Nov-24
IG Live December 2: The Weight of Wegovy Medpage Today17:01 27-Nov-24
Tirzepatide for Weight Reduction in Chinese Adults With Obesity Journal of American Medical Associations16:44 27-Nov-24
Tirzepatide for Weight Reduction in Chinese Adults With Obesity—Reply Journal of American Medical Associations16:44 27-Nov-24
Shaquille O’Neal Jokes that He's 'Ozempic FBI' as He Teases Charles Barkley for His Weight Loss: 'I'm Snitching' People16:38 27-Nov-24
Tirzepatide shows powerful diabetes-prevention effect in three-year trial ScienceDaily13:14 27-Nov-24
Epic Systems looked at 277 million patient records. Here's some of what the company found Wisconsin State Journal11:54 27-Nov-24
Zepbound Slashes Diabetes Risk in Obese Users HealthDay11:09 27-Nov-24
Amgen's big reveal of obesity data falls a little flat pharmaphorum09:53 27-Nov-24
Amgen's big reveal of obesity data falls a bit flat pharmaphorum09:43 27-Nov-24
The Ultimate Pharmaceutical Stock to Buy With $1,000 Right Now The Motley Fool09:39 27-Nov-24
Amgen share price plummets despite Phase II weight loss success Clinical Trials Arena09:29 27-Nov-24
Biden Seeks Coverage for GLP-1 RA Medications by Medicare, Medicaid HealthDay00:07 27-Nov-24
Hydreight Reports Record Topline¹ Revenue of $6.12M in Q3-2024 (YOY Increase of 54%) and achieved positive Adjusted… GlobeNewswire (Press Release)23:02 26-Nov-24
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs American Journal of Managed Care21:38 26-Nov-24
S&P 500 and Nasdaq close at record highs despite trade jitters Proactive Investors (US)21:29 26-Nov-24
S&P 500 eyes fresh record following release of Fed meeting minutes Proactive Investors (US)20:28 26-Nov-24
Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaid Medpage Today19:39 26-Nov-24
November 2024 Dispatch for the CV Team TCTMD19:38 26-Nov-24
Various unmet needs exist in Multiple Myeloma treatment; Our novel therapy’s early data shows remarkable response:… The Financial Express19:35 26-Nov-24
Thanksgiving on Ozempic: 5 rules for eating and dosing during the holidays Business Insider18:42 26-Nov-24
Novo Nordisk, Eli Lilly shares rise as Biden expanse coverage to anti-obesity drugs Proactive Investors (US)18:06 26-Nov-24
Obesity drugmaker stocks gain as Biden proposes expanded insurance coverage Proactive Investors (US)17:56 26-Nov-24
Public warned of health risks as more go online to illegally secure weight-loss jab Ozempic The Irish Independent17:34 26-Nov-24
Obesity drugmaker stocks gain as Biden proposal expands coverage for anti-obesity medications Proactive Investors (US)17:25 26-Nov-24

      
            
      
    view more headlines
   
      
      
      
6 Dec 21:50
   
About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.
Tirzepatide

About our Tirzepatide news

Health Top Stories

UK Top Stories

World Top Stories
